Enabling Faster Drug Discovery in the Cloud

Cryo-EM has emerged as a powerful tool for enabling rapid advances in drug discovery. The scale, simplicity, and economics of AWS promises to transform cryo-EM workflows even further.

However, processing and analyzing large cryo-EM datasets in AWS requires the right architecture and the right data platform.

Join this chat with Baris Guler, HPC Practice Manager at Clovertex to learn:

  • How cryo-EM is impacting drug discovery and the main challenges that exist
  • Why traditional storage approaches aren’t meeting the demands of cryo-EM applications like CryoSPARC
  • How they leverage WEKA with AWS to enable faster drug discovery workflows
  • What benchmarks they have seen and recommendations you can use
Register for: Watch the Chat


  • Speakers

    Baris Guler

    HPC Practice Manager

  • Speakers

    Phil Curran

    Cloud Strategist